Elissa A Driggin, MD

Margaret McEntegart, MD, serves as Director of Complex PCI and CTO Programs at Columbia University Irving Medical Center, leading one of New York City’s premier programs for complex coronary care. She also holds the position of Director of the Cardiac Catheterization Laboratories at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital.An internationally recognized clinician and researcher, Dr. McEntegart brings extensive experience to her work at Columbia. Before joining the institution, she was a consultant interventional cardiologist at Golden Jubilee National Hospital in Scotland, where she helped establish and lead the CTO and Complex PCI Program. She also directed the MitraClip service and contributed to the early development of the transcatheter aortic valve replacement (TAVR) program.Dr. McEntegart has played a central role as principal investigator in numerous clinical trials at local, national, and international levels. She co-supervised Ph.D. research fellows in interventional cardiology with Professor Colin Berry and founded the Glasgow Coronary Core Lab, which supported critical research efforts including the UK T-TIME trial and the BCIS-REVIVED study.At Columbia, Dr. McEntegart is committed to education and mentorship. She plays an active role in training interventional cardiology fellows, guiding junior faculty, and supporting professional development across the cardiovascular care team.

Dr. Christine Kim Garcia is the Frode-Jensen Professor of Medicine at Columbia University Irving Medical Center. Her laboratory studies the genetic basis of lung disease, including pulmonary fibrosis. She is the Chief of Pulmonary, Allergy and Critical Care Medicine Division within the Department of Medicine, a member of the Center for Precision Medicine and Genomics and an affiliate of the Institute for Genomic Medicine.

Dr. Raza is a Professor of Medicine and Director of the MDS Center at Columbia University in New York, NY. She started her research in Myelodysplastic Syndromes (MDS) in 1982 and moved to Rush University, Chicago, Illinois in 1992, where she was the Charles Arthur Weaver Professor in Oncology and Director, Division of Myeloid Diseases. The MDS Program, along with a Tissue Repository containing more than 50,000 samples from MDS and acute leukemia patients was successfully relocated to the University of Massachusetts in 2004 and to Columbia University in 2010. Before moving to New York, Dr. Raza was the Chief of Hematology Oncology and the Gladys Smith Martin Professor of Oncology at the University of Massachusetts in Worcester. She has published the results of her laboratory research and clinical trials in prestigious, peer-reviewed journals such as The New England Journal of Medicine, Nature, Blood, Cancer, Cancer Research, the British Journal of Hematology, Leukemia, and Leukemia Research. Dr. Raza serves on numerous national and international panels as a reviewer, consultant, and advisor and is the recipient of a number of awards.